The Course Directors of the HCC-LIVE Conference invite the submission of abstracts regarding advances in therapeutics, diagnosis, pathogenesis, and management of hepatocellular carcinoma.

Our goal is to provide a comprehensive update on the status of research and to stimulate collaborations, recruitment of subjects, and ideas for the development of other studies. Authors may submit abstracts of completed work, work in progress, or work presented elsewhere within the past 12 months. All abstracts will be peer-reviewed and selected for poster or podium presentation.

The deadline for receipt of abstracts is Friday, December 15, 2023. All submitting authors will receive confirmation of their abstract submission via email.

Abstracts will be selected for podium presentations or poster presentations based on scientific merit. Notification of acceptance for podium and poster presentations will be sent by email on Monday, January 8, 2024